Alignment Healthcare, Inc. (NASDAQ:ALHC) is under a securities law investigation initiated by law firm Kaplan Fox & Kilsheimer LLP following claims from a former company executive. A whistleblower complaint filed on July 8, 2026, accuses the company of accounting irregularities that inflated previously reported financial figures. On the same day, ALHC shares dropped $4.02, or 16.7%, closing at $20.03 per share, marking a notable single-day decline that investors are monitoring closely.
The whistleblower complaint, filed by a former executive, alleges that Alignment Healthcare engaged in "accounting irregularities" that "artificially inflated" previously reported and forecasted financial results. The complaint focuses on Adjusted EBITDA, a non-GAAP metric highlighted as central to the company’s financial reporting and executive compensation. It further claims that "millions of dollars in operating...
Chinese authorities have ordered major e-commerce platforms to remove 35 online stores operating under the name "Hong Kong Pharmacy" as part of a crackdown on fraudulent medical marketing, the Nati...